XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

Earnings Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Schedule of Components of Denominator for Computation of Basic and Diluted Earnings Per Share | The following table sets forth the components of the denominator for the computation of basic and diluted earnings per share for net loss attributable to Community Health Systems, Inc. common stockholders:
|  | Three Months Ended |
|  | March 31, |
|  | 2022 |  |  | 2021 |
Weighted-average number of shares outstanding — basic |  |  | 127,818,209 |  |  |  | 125,753,278 |
Effect of dilutive securities: |  |  |  |  |  |  |  |
Restricted stock awards |  |  | — |  |  |  | — |
Employee stock options |  |  | — |  |  |  | — |
Other equity-based awards |  |  | — |  |  |  | — |
Weighted-average number of shares outstanding — diluted |  |  | 127,818,209 |  |  |  | 125,753,278 |
Schedule of Antidilutive Securities | The Company generated a loss attributable to Community Health Systems, Inc. common stockholders for both of the three-month periods ended March 31, 2022 and 2021, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated income during the three months ended March 31, 2022 and 2021, the effect of restricted stock awards, employee stock options, and other equity-based awards on the diluted shares calculation would have been an increase of 2,198,436 shares and 2,267,756 shares, respectively.
|  | Three Months Ended |
|  | March 31, |
|  | 2022 |  |  | 2021 |
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive: |  |  |  |  |  |  |  |
Employee stock options and restricted stock awards |  |  | 1,367,000 |  |  |  | 858,586 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration